Genomic Health, Inc. Sede Secondaria n. MI/1 secures contract for Diagnostic Systems-Performance and reporting genomic profiling tests for patients with invasive prison of the breast type Her2-negative in the initial phase

Italy, June 17 -- Italy based Genomic Health, Inc. Sede Secondaria n. MI/1 has secured contract from ORG-0001 for Diagnostic Systems-Performance and reporting genomic profiling tests for patients with invasive prison of the breast type Her2-negative in the initial phase. The value of the contract is worth 81900000 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....